We are live on ! Find out more
PA

Pinnacle Associates Portfolio holdings

AUM $7.78B
1-Year Est. Return 45.07%
This Fund
S&P 500
This Quarter Est. Return
+14.33%
1 Year Est. Return
+45.07%
3 Year Est. Return
+102.47%
5 Year Est. Return
+115.95%
10 Year Est. Return
+586.2%
AUM
$6.91B
AUM Growth
+$82.5M
Cap. Flow
-$567M
Cap. Flow %
-8.2%
Top 10 Hldgs %
24.12%
Holding
865
New
42
Increased
270
Reduced
470
Closed
20

Top Buys

Rank Stock Value
1
VTI icon
Vanguard Total Stock Market ETF
VTI
+$34.6M
2
WMT icon
Walmart Inc
WMT
+$12.2M
3
NVDA icon
NVIDIA
NVDA
+$8.11M
4
EOLS icon
Evolus
EOLS
+$7.02M
5
ABBV icon
AbbVie
ABBV
+$6.93M

Sector Composition

Rank Sector Weight
1 Technology 23.46%
2 Financials 11.35%
3 Healthcare 9.92%
4 Industrials 8.66%
5 Communication Services 7.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WELL icon
176
Welltower
WELL
$175B
$8.21M 0.12%
53,385
-2,092
-4% -$313K
COP icon
177
ConocoPhillips
COP
$141B
$8.09M 0.12%
90,143
+3,112
+4% +$280K
MET icon
178
MetLife
MET
$61.2B
$8.09M 0.12%
100,555
-342
-0.3% -$26.4K
GDS icon
179
GDS Holdings
GDS
$6.29B
$7.97M 0.12%
260,807
-1,980
-0.8% -$50.2K
RY icon
180
Royal Bank of Canada
RY
$291B
$7.91M 0.11%
60,104
-26
-0% -$3.18K
SSYS icon
181
Stratasys
SSYS
$700M
$7.86M 0.11%
684,853
-181,843
-21% -$1.84M
TXN icon
182
Texas Instruments
TXN
$255B
$7.82M 0.11%
37,670
+811
+2% +$144K
VIG icon
183
Vanguard Dividend Appreciation ETF
VIG
$112B
$7.8M 0.11%
38,129
-2,579
-6% -$500K
HXL icon
184
Hexcel
HXL
$8.28B
$7.8M 0.11%
137,993
-46,461
-25% -$2.46M
RMD icon
185
ResMed
RMD
$29.5B
$7.68M 0.11%
29,763
-3,354
-10% -$800K
ICHR icon
186
Ichor Holdings
ICHR
$2.73B
$7.59M 0.11%
386,542
+1,099
+0.3% +$20.1K
EMR icon
187
Emerson Electric
EMR
$83.6B
$7.46M 0.11%
55,947
-567
-1% -$65K
MTCH icon
188
Match Group
MTCH
$9.05B
$7.45M 0.11%
241,196
-104,531
-30% -$3.13M
VWO icon
189
Vanguard FTSE Emerging Markets ETF
VWO
$120B
$7.29M 0.11%
147,365
+3,660
+3% +$170K
UEC icon
190
Uranium Energy
UEC
$4.9B
$7.2M 0.1%
1,058,762
-400,474
-27% -$2.24M
WERN icon
191
Werner Enterprises
WERN
$2.42B
$7.04M 0.1%
257,289
-97,910
-28% -$2.68M
NVS icon
192
Novartis
NVS
$297B
$7.03M 0.1%
58,075
-626
-1% -$70.6K
TLS icon
193
Telos
TLS
$346M
$6.99M 0.1%
2,205,819
-488,387
-18% -$1.27M
SHEL icon
194
Shell
SHEL
$239B
$6.95M 0.1%
98,639
-44
-0% -$2.95K
XLY icon
195
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.6B
$6.89M 0.1%
63,440
-1,016
-2% -$104K
CYTK icon
196
Cytokinetics
CYTK
$10.9B
$6.89M 0.1%
208,527
-61,908
-23% -$2.15M
LHX icon
197
L3Harris
LHX
$56.5B
$6.88M 0.1%
27,447
-733
-3% -$168K
CL icon
198
Colgate-Palmolive
CL
$73.6B
$6.88M 0.1%
75,703
-4,410
-6% -$403K
IWF icon
199
iShares Russell 1000 Growth ETF
IWF
$120B
$6.88M 0.1%
64,828
-4,224
-6% -$404K
TGNA
200
DELISTED
TEGNA Inc
TGNA
$6.67M 0.1%
397,932
-97,824
-20% -$1.63M

Similar funds

Pinnacle Associates's Q2 2025 Portfolio in Review

As of Q2 2025, Pinnacle Associates held 865 positions worth $6.91B, up 1.2% from $6.82B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Pinnacle Associates withdrew a net $567M in Q2 2025, closing 20 positions and reducing 470 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $17.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Pinnacle Associates opened a new position in Evolus worth $6.32M.

  • Pinnacle Associates's largest Q2 2025 buy was Evolus: 685,960 shares worth $6.32M.
  • Pinnacle Associates added most to Vanguard Total Stock Market ETF in Q2 2025, an estimated $34.6M increase.
  • Pinnacle Associates's biggest Q2 2025 reduction was Johnson & Johnson, cutting an estimated $335M.
  • Pinnacle Associates fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $17.9M.
  • Pinnacle Associates's ten largest holdings make up 24% of its $6.91B portfolio in Q2 2025.
  • Pinnacle Associates opened 42 new positions and closed 20 in Q2 2025.
  • Pinnacle Associates's portfolio value rose 1.2% quarter-over-quarter to $6.91B.

Based on Pinnacle Associates's 13F filing for Q2 2025, filed 4 Aug 2025.